Centene Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Centene Corporation - overview
Established
1984
Location
St. Louis, MO, US
Primary Industry
Healthcare
About
Centene Corporation, based in the US, provides government-sponsored healthcare services, focusing on affordable, quality solutions tailored for Medicaid and Medicare members and families utilizing the Health Insurance Marketplace. Centene Corporation is dedicated to offering healthcare solutions primarily through managed care plans. Established in 1984 and headquartered in St. Louis, Missouri, the company has expanded its operations across multiple states.
It was founded by Anastasios Koilakos, Angelina Musik, and several others who aimed to address the healthcare needs of underserved communities. The current CEO is Aaron Schubach. Centene does not have a history of major business pivots but has grown through strategic expansions and partnerships in the healthcare sector. Centene Corporation is a leading provider of government-sponsored healthcare services, primarily focused on delivering affordable and high-quality healthcare solutions to Medicaid and Medicare members, as well as individuals and families utilizing the Health Insurance Marketplace.
Their core product offerings include managed care plans tailored to meet diverse population needs, ensuring access to culturally sensitive and locally delivered services. Centene is the largest Medicaid managed care organization in the United States and significantly participates in the Health Insurance Marketplace, serving clients in states like California, Texas, Florida, and New York, while partnering with local organizations to enhance service access. Centene Corporation reported revenue of USD 145. 51 bn for the year 2024, supported by its managed care services funded through government programs and private insurance models.
The firm generates income through capitation arrangements and B2B transactions with state Medicaid programs and the federal government, enhancing its financial predictability. Its extensive network and partnerships allow Centene to maintain a diverse client portfolio and optimize revenue through collaborative agreements that align with community health transformation.
Primary Industry
Healthcare
Sub Industries
Health Insurance, Healthcare, Hospitals
Website
www.centene.com
Total Amount Raised
Subscriber access only
Centene Corporation - timeline of key events
Centene Corporation - financials
| Fiscal Year Ended | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 16,560,000,000 | 22,760,000,000 | 40,607,000,000 | 48,382,000,000 | 60,116,000,000 | 74,639,000,000 | 111,115,000,000 | 125,982,000,000 | 144,547,000,000 | - | - | - |
| % Revenue Growth (YoY) | - | 37.4% | 78.4% | 19.1% | 24.3% | 24.2% | 48.9% | 13.4% | 14.7% | - | - | - |
| EBITDA (USD) | 553,000,000 | 816,000,000 | 1,538,000,000 | 1,560,000,000 | 1,953,000,000 | 2,424,000,000 | 4,341,000,000 | 3,260,000,000 | 2,871,000,000 | - | - | - |
| Operating Income (USD) | 464,000,000 | 705,000,000 | 1,260,000,000 | 1,199,000,000 | 1,458,000,000 | 1,781,000,000 | 3,082,000,000 | 1,784,000,000 | 1,318,000,000 | - | - | - |
| Operating Margin | 2.8% | 3.1% | 3.1% | 2.5% | 2.4% | 2.4% | 2.8% | 1.4% | 0.9% | - | - | - |
| % EBITDA Margin | 3.3% | 3.6% | 3.8% | 3.2% | 3.2% | 3.2% | 3.9% | 2.6% | 2.0% | - | - | - |
| NET Income (USD) | 264,000,000 | 357,000,000 | 561,000,000 | 808,000,000 | 894,000,000 | 1,309,000,000 | 1,794,000,000 | 1,336,000,000 | 1,202,000,000 | - | - | - |
| % Net Margin | 1.6% | 1.6% | 1.4% | 1.7% | 1.5% | 1.8% | 1.6% | 1.1% | 0.8% | - | - | - |
Centene Corporation - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Announced | Diameter Health, Inc. | - | ||||||||
| Add-on | Completed | Ribera Salud | - | ||||||||
| Buyout | Announced | PANTHERx Rare | - | ||||||||
| Add-on | Completed | U.S. Medical Management, LLC | - | ||||||||
| Add-on, Trade Sale | Completed | RubiconMD, Inc. | - |
Displaying 1 - 5 of 8
Centene Corporation - employee data
Centene Corporation - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Advisory Board Member | BM | ||||||
| Member of Termination Appeals Board | BM | ||||||
| President, Board of Directors, NV | BM | ||||||
| President, Chairman of Board | BM | ||||||
| Board of Directors, Aledade Laffey ACO | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.